The Centers for Medicare & Medicaid Services (CMS) officially released the Calendar Year (CY) 2027 Medicare Physician Fee Schedule (MPFS) proposed rule on July 14, setting the stage for a comprehensive evaluation of how healthcare providers will be reimbursed for services provided to the nation’s senior and disabled populations. The release of the proposed rule initiates a critical 60-day public comment period, during which medical societies, healthcare organizations, and individual practitioners are encouraged to provide feedback on the proposed regulatory changes. For the Endocrine Society and its members, the rule represents a pivotal moment in the ongoing effort to ensure that reimbursement rates reflect the increasing complexity of managing chronic endocrine conditions and the rising costs of maintaining a modern medical practice.
The MPFS serves as the primary mechanism through which Medicare determines payment rates for more than 1.3 million clinicians. Because many private insurers tie their own reimbursement schedules to Medicare rates, the annual updates provided by CMS have far-reaching implications for the entire U.S. healthcare economy. This year’s proposal arrives at a time of significant fiscal tension within the medical community, as providers face the dual pressures of post-pandemic inflation and a regulatory framework that often results in year-over-year payment reductions due to statutory budget neutrality requirements.
Chronology of Recent Regulatory and Legislative Developments
The landscape of Medicare physician payment underwent a rapid shift over the course of 48 hours in mid-July, highlighting the multi-pronged approach required to address physician reimbursement.
On July 14, CMS published the CY 2027 MPFS proposed rule. This document, which spans hundreds of pages, details proposed changes to the conversion factor—the dollar amount used to calculate payments—as well as updates to clinical labor pricing, professional liability insurance costs, and the valuation of specific medical codes. Following the release, CMS published a detailed fact sheet summarizing the primary objectives of the rule, which include expanding access to behavioral health, strengthening primary care, and refining the Merit-based Incentive Payment System (MIPS).
The following day, July 15, legislative action complemented the regulatory announcement. The bipartisan chairs of the GOP and Democratic Doctors Caucus introduced the "Patients First Act." This legislation is designed to address what many in the medical community describe as a "broken" payment system by introducing a permanent inflationary update to the MPFS. The timing of the bill’s introduction is strategic, aiming to influence the debate as stakeholders review the CMS proposed rule.
The Endocrine Society has outlined a clear timeline for its response to these developments. Throughout the month of August, the Society’s advocacy and regulatory teams will conduct an in-depth analysis of the 2027 proposed rule to identify specific impacts on endocrinology practices. This analysis will culminate in a formal comment letter to be submitted to CMS by the September 14 deadline.
The Patients First Act: A Structural Shift in Reimbursement
A central component of the current advocacy effort is the support for the Patients First Act. For years, physician groups have argued that the current Medicare payment system is unsustainable because it lacks an automatic mechanism to account for inflation. Unlike hospitals, skilled nursing facilities, and other healthcare entities that receive annual "market basket" updates, physician payments are subject to a "conversion factor" that frequently decreases to balance the federal budget.
The Patients First Act seeks to rectify this by tying the Medicare Physician Fee Schedule to the Medicare Economic Index (MEI). The MEI is a measure of the inflation faced by physicians in their practice costs, including rent, utilities, medical equipment, and staff wages. Under the proposed legislation, physicians would receive an annual update equal to the MEI minus 1%. While this does not fully cover the entirety of inflationary pressure, it represents a significant departure from the current system of flat or declining rates.
The Endocrine Society has specifically urged the sponsors of the bill to ensure that the legislation protects non-procedural specialists. Endocrinologists primarily bill through Evaluation and Management (E/M) services—the codes used for office visits and outpatient consultations. Because endocrinology involves the long-term management of complex, chronic diseases like diabetes, osteoporosis, and thyroid disorders, these "cognitive" services are the lifeblood of the specialty. The Society’s advocacy focuses on ensuring that the Patients First Act does not inadvertently favor surgical or procedural specialties over those that rely on diagnostic and management-based care.
Data and Economic Context: The Widening Gap
The push for legislative and regulatory reform is supported by a growing body of economic data. According to analysis from the American Medical Association (AMA) and other physician advocacy groups, when adjusted for inflation in practice costs, Medicare physician payment has effectively declined by approximately 26% between 2001 and 2024. During this same period, the cost of running a medical practice has continued to climb, driven by labor shortages, the high cost of electronic health record (EHR) maintenance, and general economic inflation.
The MEI, which the Patients First Act seeks to utilize, has consistently outpaced the actual updates provided to the MPFS conversion factor. In recent years, the gap between the cost of providing care and the reimbursement received for that care has forced many independent practices to consolidate with larger hospital systems or, in some cases, limit the number of Medicare patients they accept. For endocrinology, a field already facing a projected shortage of providers, these financial pressures threaten to further restrict patient access to specialized care.
Implications for Endocrinology and Cognitive Specialties
The CY 2027 proposed rule and the accompanying legislation carry specific implications for the field of endocrinology. Unlike specialties that generate revenue through high-volume procedures, endocrinologists provide value through clinical decision-making, patient education, and the fine-tuning of medication regimens.
One of the primary areas of interest in the MPFS is the valuation of E/M codes. In previous years, CMS has made efforts to increase the value of these codes to better reflect the complexity of modern office visits. However, because of budget neutrality laws, any increase in the value of one set of codes must be offset by a decrease in the overall conversion factor. This "zero-sum" environment often pits different medical specialties against one another.
The Endocrine Society’s upcoming analysis will look closely at how the 2027 rule handles:
- Telehealth Services: Since the pandemic, endocrinologists have heavily utilized telehealth for routine management of conditions like diabetes. The proposed rule will dictate whether current flexibilities and payment parities are maintained.
- Chronic Care Management (CCM): CMS has been exploring ways to better compensate providers for the time spent coordinating care outside of face-to-face visits. For endocrinologists, who often coordinate with primary care, ophthalmology, and podiatry for a single patient, CCM updates are vital.
- The G2211 Code: This add-on code for complex office visits was introduced to recognize the inherent complexity of longitudinal care. The Society will be monitoring any proposed changes to how this code is utilized or reimbursed.
Official Responses and Stakeholder Perspectives
While CMS characterizes the proposed rule as a step toward "strengthening the Medicare program and protecting the health and well-being of the people it serves," physician organizations have expressed a more cautious outlook.
The Endocrine Society’s stance is one of proactive advocacy. In preliminary statements, the Society emphasized that it will continue to work with bipartisan leaders to ensure that endocrinologists are "adequately reimbursed for the care they provide." The focus remains on the "Patients First Act" as a long-term solution to the annual "cliff" that physicians face when CMS releases its final rules each autumn.
Members of the GOP and Democratic Doctors Caucus, which includes physicians currently serving in Congress, have argued that the current system undermines the stability of the healthcare workforce. By introducing the Patients First Act, they aim to provide a predictable fiscal environment that allows practices to invest in staff and technology without the fear of sudden revenue drops.
Broader Impact on the Healthcare System
The outcome of the CY 2027 MPFS rulemaking process and the fate of the Patients First Act will have a profound impact on the future of American healthcare delivery. If reimbursement continues to lag behind inflation, the trend of physician burnout and early retirement is expected to accelerate. This is particularly concerning for endocrinology, where the demand for services is rising due to the increasing prevalence of obesity and type 2 diabetes.
Furthermore, the transition from independent practice to hospital-owned models often results in higher costs for the Medicare program and for patients, as hospital-based services frequently command higher facility fees than independent clinics. By advocating for fair reimbursement in the MPFS, the Endocrine Society and its allies are not only fighting for the financial health of their members but also for the preservation of a diverse and accessible healthcare landscape.
As the September 14 deadline for comments approaches, the medical community will be watching closely to see if CMS is willing to adjust its proposals based on stakeholder feedback, and whether Congress will take the necessary steps to pass the Patients First Act. For now, endocrinologists are encouraged to review the Society’s forthcoming analysis in August to understand how these high-level policy shifts will translate to their daily practice and the patients they serve.
